首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide
【24h】

International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide

机译:建立国际卫生组织第二项国际流感嗜血杆菌b型多糖标准的国际合作研究

获取原文
获取原文并翻译 | 示例
           

摘要

In this report we present the results of a collaborative study for the preparation and calibration of a replacement International Standard (IS) for Haemophilus influenzae type b polysaccharide (polyribosyl ribitol phosphate; 5-D-ribitol-(1 -> 1)-beta-D-ribose-3-phosphate; PRP). Two candidate preparations were evaluated. Thirteen laboratories from 9 different countries participated in the collaborative study to assess the suitability and determine the PRP content of two candidate standards. On the basis of the results from this study, Candidate 2 (NIBSC code 12/306) has been established as the 2nd WHO IS for PRP by the Expert Committee of Biological Standards of the World Health Organisation with a content of 4.904 +/- 0.185 mg/ampoule, as determined by the ribose assays carried out by 11 of the participating laboratories. (C) 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
机译:在本报告中,我们介绍了一项合作研究的结果,该研究为流感嗜血杆菌b型多糖(聚核糖核糖醇磷酸; 5-D-核糖醇-(1-> 1)-β- D-核糖-3-磷酸; PRP)。评价了两种候选制剂。来自9个不同国家的13个实验室参加了合作研究,以评估适用性并确定两个候选标准的PRP含量。根据这项研究的结果,候选者2(NIBSC代码12/306)已被世界卫生组织生物标准专家委员会确定为PRP的第二个WHO IS,含量为4.904 +/- 0.185毫克/安瓿,由11个参与实验室进行的核糖测定确定。 (C)2015年国际生物标准化联盟。由Elsevier Ltd.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号